Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 894

Results For "ED"

9062 News Found

Alembic gets USFDA approval for Lurasidone Hydrochloride tablets
News | May 15, 2021

Alembic gets USFDA approval for Lurasidone Hydrochloride tablets

Lurasidone Hydrochloride tablets are also indicated for adjunctive treatment with lithium or valproate in adult patients with major depressive episode associated with bipolar I disorder


Granules to donate 16 crores Paracetamol tablets to Telangana
News | May 15, 2021

Granules to donate 16 crores Paracetamol tablets to Telangana

The company will provide one crore tablets every week, starting from 12th May 2021, aggregating to 16 crore tablets worth Rs. 8 crores over the next 4 months


Torrent Pharma enters into agreement with Lilly for Baricitinib for Covid-19 in India
News | May 13, 2021

Torrent Pharma enters into agreement with Lilly for Baricitinib for Covid-19 in India

The agreement will help ensure wider reach and access to patients in India


Govt. ramps up Amphotericin B manufacturing to fight Mucormycosis
News | May 12, 2021

Govt. ramps up Amphotericin B manufacturing to fight Mucormycosis

The Department of Pharma has allocated this drug amongst the states/UTs based on expected supply that will be available from May 10 to May 31, 2021


Brinton triples production of COVID-19 drug Favipiravir
News | May 12, 2021

Brinton triples production of COVID-19 drug Favipiravir

Favipiravir is close to Remdesivir, Remdesivir is used to treat moderate to severe cases while Favipiravir is used to treat mild to moderate cases


CRISIL assigns 'Positive' outlook to Jubilant Pharmova's long-term rating
News | May 11, 2021

CRISIL assigns 'Positive' outlook to Jubilant Pharmova's long-term rating

The rating withdrawal is based on the company’s request and in line with CRISIL Rating’s policy on withdrawal of ratings.


Alembic reports net profit of Rs. 71.94 Cr in Q4FY21
News | May 11, 2021

Alembic reports net profit of Rs. 71.94 Cr in Q4FY21

Alembic has reported total income of Rs.83.79 crores during the FY ended March 31, 2021


Remdesivir allocation made upto 16th May: Gowda
News | May 10, 2021

Remdesivir allocation made upto 16th May: Gowda

State governments and UTs have been asked to monitor proper distribution within the state/UT covering government and private hospitals


Jubilant Pharma wins over Bracco's legal appeals in the US Court of Appeals
News | May 10, 2021

Jubilant Pharma wins over Bracco's legal appeals in the US Court of Appeals

Jubilant successfully challenged Bracco's patent infringement claims in an Inter Parties Review (IPR) proceeding before the U.S. Patent Office


Cipla signs agreement with Lilly to expand access to COVID-19 treatment in India
News | May 10, 2021

Cipla signs agreement with Lilly to expand access to COVID-19 treatment in India

Baricitinib was issued a restricted emergency use approval by the Central Drugs Standard Control Organization (CDSCO)